Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT03457454
Other study ID # 201704046
Secondary ID U01CA209861-01A1
Status Completed
Phase
First received
Last updated
Start date September 8, 2017
Est. completion date March 18, 2021

Study information

Verified date March 2021
Source Washington University School of Medicine
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

The investigators will conduct pre-implementations assessments of primary care clinics within a rural health system to determine current practices and capacities regarding colorectal cancer (CRC) screening and follow-up, preferred evidence-based interventions (EBIs) to improve follow-up, and factors that could influence successful implementation and eventual impact of a multi-level intervention to increase timely and complete follow-up after positive fecal occult blood test (FOBT) in rural patients.


Recruitment information / eligibility

Status Completed
Enrollment 431
Est. completion date March 18, 2021
Est. primary completion date March 18, 2021
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria for Primary Care Provider/Staff Participants -Eligible providers and staff include physicians, nurse practitioners, nurses, case managers, medical assistants, administrative staff, or other employees of the clinic involved in the cancer screening and follow-up process. Inclusion Criteria for Patient Participants (Interview) -Positive FOBT or colonoscopy Inclusion Criteria for Patient Participants (Survey) - 50 years of age or older - Had a colonoscopy at one of Southern Illinois Healthcare's facilities within the last 24 months Inclusion Criteria for Colonoscopy Provider/Staff Participants -Provider and a staff or mid-level provider in each office (5 colonoscopy providers in the Southern Illinois Healthcare region) Exclusion Criteria for Primary Care Provider/Staff Participants -None Exclusion Criteria for Patient Participants (Interview) - Negative FOBT or colonoscopy - Exclusion Criteria for Patient Participants (Survey) - Younger than 50 years of age Exclusion Criteria for Colonoscopy Provider/Staff Participants None

Study Design


Related Conditions & MeSH terms


Intervention

Other:
Primary Care Provider/Staff Participants Interview
-Approximately a 30 minute interview
Patient Participant Interview
-Approximately 45-60 minute interview
Patient Participant Anonymous Survey
-Survey completion will take approximately 15 minutes
Colonoscopy Provider/Staff Participants Interviews
-Approximately a 30 minute interview

Locations

Country Name City State
United States Southern Illinois Healthcare Carbondale Illinois
United States Washington University School of Medicine Saint Louis Missouri

Sponsors (3)

Lead Sponsor Collaborator
Washington University School of Medicine National Cancer Institute (NCI), National Institutes of Health (NIH)

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary Determine current practice and capacity regarding screening and follow-up of colorectal cancer screening at rural health clinics -This will be measured by interviews Through completion of study (estimated to be 18 months)
Primary Assess factors that could influence implementation of multi-level EBIs -This will be measured by interviews Through completion of study (estimated to be 18 months)
Primary Evaluate the capacity for colonoscopy and diagnostic follow-up by identifying those clinics/practitioners who deliver colonoscopy -This will be measured by interviews Through completion of study (estimated to be 18 months)
Primary Assess the care coordination and communication with primary care providers by colonoscopy clinics/practitioners -This will be measured by interviews Through completion of study (estimated to be 18 months)
See also
  Status Clinical Trial Phase
Active, not recruiting NCT05551052 - CRC Detection Reliable Assessment With Blood
Recruiting NCT06006390 - CEA Targeting Chimeric Antigen Receptor T Lymphocytes (CAR-T) in the Treatment of CEA Positive Advanced Solid Tumors Phase 1/Phase 2
Active, not recruiting NCT04088955 - A Digimed Oncology PharmacoTherapy Registry
Recruiting NCT06010862 - Clinical Study of CEA-targeted CAR-T Therapy for CEA-positive Advanced/Metastatic Malignant Solid Tumors Phase 1
Terminated NCT01347645 - Irinotecan Plus E7820 Versus FOLFIRI in Second-Line Therapy in Patients With Locally Advanced or Metastatic Colon or Rectal Cancer Phase 1/Phase 2
Completed NCT03390907 - Hybrid APC Assisted EMR for Large Colon Polyps N/A
Recruiting NCT03175224 - APL-101 Study of Subjects With NSCLC With c-Met EXON 14 Skip Mutations and c-Met Dysregulation Advanced Solid Tumors Phase 2
Completed NCT04079478 - The AID Study: Artificial Intelligence for Colorectal Adenoma Detection
Active, not recruiting NCT04057274 - Acute Effect of modeRate-intensity aerOBIc Exercise on Colon Cancer Cell Growth N/A
Recruiting NCT03190941 - Administering Peripheral Blood Lymphocytes Transduced With a Murine T-Cell Receptor Recognizing the G12V Variant of Mutated RAS in HLA-A*11:01 Patients Phase 1/Phase 2
Not yet recruiting NCT05147545 - Impact of Exercise and Hyperlipidic Meal on Free Circulating DNA in Patients With Metastatic Colonic Cancer and Healthy Subjects N/A
Recruiting NCT05026268 - The Laparoscopic Right Colectomy With Intracoroporeal Anastomosis N/A
Not yet recruiting NCT03277235 - Effect of a Resilience Model-Based Care Plan in Newly Diagnosed Colorectal Cancer Patients N/A
Active, not recruiting NCT02730702 - Colon Cancer Risk-stratification Via Optical Analysis of Rectal Ultrastructure
Active, not recruiting NCT02959541 - PK/PD Investigation of Calciumfolinat in Blood, Tumor and Adjacent Mucosa in Patient With Colon Cancer N/A
Completed NCT02810652 - Perioperative Geriatrics Intervention for Older Cancer Patients Undergoing Surgical Resection N/A
Recruiting NCT02577627 - Multi-Indication, Retrospective Oncological Study to Validate the Accuracy in Predicting TTP by PrediCare in Patients Under SOC N/A
Terminated NCT02628535 - Safety Study of MGD009 in B7-H3-expressing Tumors Phase 1
Recruiting NCT02526836 - Complete Mesocolic Excision With Central Vessel Ligation Compared With Conventional Surgery for Colon Cancer Phase 2/Phase 3
Completed NCT02243267 - GI SPORE Colon Biosample Protocol N/A